Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Autoimmune Disorders Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Bridge Therapy
1.2.3 Recombinant Technology
1.2.4 Fecal Bacteriotherapy
1.2.5 Hematopoietic Stem-cell Transplantation
1.2.6 Phototherapy
1.2.7 Helminthic Therapy
1.2.8 Activation-induced Assays
1.3 Market by Application
1.3.1 Global Autoimmune Disorders Treatment Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Systemic Autoimmune Diseases
1.3.3 Localized Autoimmune Diseases
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Autoimmune Disorders Treatment Market Perspective (2018-2033)
2.2 Autoimmune Disorders Treatment Growth Trends by Region
2.2.1 Global Autoimmune Disorders Treatment Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Autoimmune Disorders Treatment Historic Market Size by Region (2018-2023)
2.2.3 Autoimmune Disorders Treatment Forecasted Market Size by Region (2024-2033)
2.3 Autoimmune Disorders Treatment Market Dynamics
2.3.1 Autoimmune Disorders Treatment Industry Trends
2.3.2 Autoimmune Disorders Treatment Market Drivers
2.3.3 Autoimmune Disorders Treatment Market Challenges
2.3.4 Autoimmune Disorders Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Autoimmune Disorders Treatment Players by Revenue
3.1.1 Global Top Autoimmune Disorders Treatment Players by Revenue (2018-2023)
3.1.2 Global Autoimmune Disorders Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Autoimmune Disorders Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Autoimmune Disorders Treatment Revenue
3.4 Global Autoimmune Disorders Treatment Market Concentration Ratio
3.4.1 Global Autoimmune Disorders Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Autoimmune Disorders Treatment Revenue in 2022
3.5 Autoimmune Disorders Treatment Key Players Head office and Area Served
3.6 Key Players Autoimmune Disorders Treatment Product Solution and Service
3.7 Date of Enter into Autoimmune Disorders Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Autoimmune Disorders Treatment Breakdown Data by Type
4.1 Global Autoimmune Disorders Treatment Historic Market Size by Type (2018-2023)
4.2 Global Autoimmune Disorders Treatment Forecasted Market Size by Type (2024-2033)
5 Autoimmune Disorders Treatment Breakdown Data by Application
5.1 Global Autoimmune Disorders Treatment Historic Market Size by Application (2018-2023)
5.2 Global Autoimmune Disorders Treatment Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Autoimmune Disorders Treatment Market Size (2018-2033)
6.2 North America Autoimmune Disorders Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Autoimmune Disorders Treatment Market Size by Country (2018-2023)
6.4 North America Autoimmune Disorders Treatment Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Autoimmune Disorders Treatment Market Size (2018-2033)
7.2 Europe Autoimmune Disorders Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Autoimmune Disorders Treatment Market Size by Country (2018-2023)
7.4 Europe Autoimmune Disorders Treatment Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Autoimmune Disorders Treatment Market Size (2018-2033)
8.2 Asia-Pacific Autoimmune Disorders Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Autoimmune Disorders Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Autoimmune Disorders Treatment Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Autoimmune Disorders Treatment Market Size (2018-2033)
9.2 Latin America Autoimmune Disorders Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Autoimmune Disorders Treatment Market Size by Country (2018-2023)
9.4 Latin America Autoimmune Disorders Treatment Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Autoimmune Disorders Treatment Market Size (2018-2033)
10.2 Middle East & Africa Autoimmune Disorders Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Autoimmune Disorders Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Autoimmune Disorders Treatment Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Autoimmune Disorders Treatment Introduction
11.1.4 Abbott Laboratories Revenue in Autoimmune Disorders Treatment Business (2018-2023)
11.1.5 Abbott Laboratories Recent Development
11.2 Roche Diagnostics
11.2.1 Roche Diagnostics Company Detail
11.2.2 Roche Diagnostics Business Overview
11.2.3 Roche Diagnostics Autoimmune Disorders Treatment Introduction
11.2.4 Roche Diagnostics Revenue in Autoimmune Disorders Treatment Business (2018-2023)
11.2.5 Roche Diagnostics Recent Development
11.3 Siemens Healthcare
11.3.1 Siemens Healthcare Company Detail
11.3.2 Siemens Healthcare Business Overview
11.3.3 Siemens Healthcare Autoimmune Disorders Treatment Introduction
11.3.4 Siemens Healthcare Revenue in Autoimmune Disorders Treatment Business (2018-2023)
11.3.5 Siemens Healthcare Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Detail
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Autoimmune Disorders Treatment Introduction
11.4.4 Johnson & Johnson Revenue in Autoimmune Disorders Treatment Business (2018-2023)
11.4.5 Johnson & Johnson Recent Development
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Detail
11.5.2 Boehringer Ingelheim Business Overview
11.5.3 Boehringer Ingelheim Autoimmune Disorders Treatment Introduction
11.5.4 Boehringer Ingelheim Revenue in Autoimmune Disorders Treatment Business (2018-2023)
11.5.5 Boehringer Ingelheim Recent Development
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Detail
11.6.2 GlaxoSmithKline Business Overview
11.6.3 GlaxoSmithKline Autoimmune Disorders Treatment Introduction
11.6.4 GlaxoSmithKline Revenue in Autoimmune Disorders Treatment Business (2018-2023)
11.6.5 GlaxoSmithKline Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Detail
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Autoimmune Disorders Treatment Introduction
11.7.4 AstraZeneca Revenue in Autoimmune Disorders Treatment Business (2018-2023)
11.7.5 AstraZeneca Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Detail
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Autoimmune Disorders Treatment Introduction
11.8.4 Sanofi Revenue in Autoimmune Disorders Treatment Business (2018-2023)
11.8.5 Sanofi Recent Development
11.9 Merck
11.9.1 Merck Company Detail
11.9.2 Merck Business Overview
11.9.3 Merck Autoimmune Disorders Treatment Introduction
11.9.4 Merck Revenue in Autoimmune Disorders Treatment Business (2018-2023)
11.9.5 Merck Recent Development
11.10 Pfizer
11.10.1 Pfizer Company Detail
11.10.2 Pfizer Business Overview
11.10.3 Pfizer Autoimmune Disorders Treatment Introduction
11.10.4 Pfizer Revenue in Autoimmune Disorders Treatment Business (2018-2023)
11.10.5 Pfizer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Autoimmune Disorders Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Bridge Therapy
Table 3. Key Players of Recombinant Technology
Table 4. Key Players of Fecal Bacteriotherapy
Table 5. Key Players of Hematopoietic Stem-cell Transplantation
Table 6. Key Players of Phototherapy
Table 7. Key Players of Helminthic Therapy
Table 8. Key Players of Activation-induced Assays
Table 9. Global Autoimmune Disorders Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 10. Global Autoimmune Disorders Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 11. Global Autoimmune Disorders Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 12. Global Autoimmune Disorders Treatment Market Share by Region (2018-2023)
Table 13. Global Autoimmune Disorders Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 14. Global Autoimmune Disorders Treatment Market Share by Region (2024-2033)
Table 15. Autoimmune Disorders Treatment Market Trends
Table 16. Autoimmune Disorders Treatment Market Drivers
Table 17. Autoimmune Disorders Treatment Market Challenges
Table 18. Autoimmune Disorders Treatment Market Restraints
Table 19. Global Autoimmune Disorders Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 20. Global Autoimmune Disorders Treatment Market Share by Players (2018-2023)
Table 21. Global Top Autoimmune Disorders Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autoimmune Disorders Treatment as of 2022)
Table 22. Ranking of Global Top Autoimmune Disorders Treatment Companies by Revenue (US$ Million) in 2022
Table 23. Global 5 Largest Players Market Share by Autoimmune Disorders Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Autoimmune Disorders Treatment Product Solution and Service
Table 26. Date of Enter into Autoimmune Disorders Treatment Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Autoimmune Disorders Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 29. Global Autoimmune Disorders Treatment Revenue Market Share by Type (2018-2023)
Table 30. Global Autoimmune Disorders Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 31. Global Autoimmune Disorders Treatment Revenue Market Share by Type (2024-2033)
Table 32. Global Autoimmune Disorders Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 33. Global Autoimmune Disorders Treatment Revenue Market Share by Application (2018-2023)
Table 34. Global Autoimmune Disorders Treatment Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 35. Global Autoimmune Disorders Treatment Revenue Market Share by Application (2024-2033)
Table 36. North America Autoimmune Disorders Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. North America Autoimmune Disorders Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America Autoimmune Disorders Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 39. Europe Autoimmune Disorders Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 40. Europe Autoimmune Disorders Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 41. Europe Autoimmune Disorders Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 42. Asia-Pacific Autoimmune Disorders Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 43. Asia-Pacific Autoimmune Disorders Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 44. Asia-Pacific Autoimmune Disorders Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 45. Latin America Autoimmune Disorders Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Latin America Autoimmune Disorders Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 47. Latin America Autoimmune Disorders Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 48. Middle East & Africa Autoimmune Disorders Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 49. Middle East & Africa Autoimmune Disorders Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 50. Middle East & Africa Autoimmune Disorders Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 51. Abbott Laboratories Company Detail
Table 52. Abbott Laboratories Business Overview
Table 53. Abbott Laboratories Autoimmune Disorders Treatment Product
Table 54. Abbott Laboratories Revenue in Autoimmune Disorders Treatment Business (2018-2023) & (US$ Million)
Table 55. Abbott Laboratories Recent Development
Table 56. Roche Diagnostics Company Detail
Table 57. Roche Diagnostics Business Overview
Table 58. Roche Diagnostics Autoimmune Disorders Treatment Product
Table 59. Roche Diagnostics Revenue in Autoimmune Disorders Treatment Business (2018-2023) & (US$ Million)
Table 60. Roche Diagnostics Recent Development
Table 61. Siemens Healthcare Company Detail
Table 62. Siemens Healthcare Business Overview
Table 63. Siemens Healthcare Autoimmune Disorders Treatment Product
Table 64. Siemens Healthcare Revenue in Autoimmune Disorders Treatment Business (2018-2023) & (US$ Million)
Table 65. Siemens Healthcare Recent Development
Table 66. Johnson & Johnson Company Detail
Table 67. Johnson & Johnson Business Overview
Table 68. Johnson & Johnson Autoimmune Disorders Treatment Product
Table 69. Johnson & Johnson Revenue in Autoimmune Disorders Treatment Business (2018-2023) & (US$ Million)
Table 70. Johnson & Johnson Recent Development
Table 71. Boehringer Ingelheim Company Detail
Table 72. Boehringer Ingelheim Business Overview
Table 73. Boehringer Ingelheim Autoimmune Disorders Treatment Product
Table 74. Boehringer Ingelheim Revenue in Autoimmune Disorders Treatment Business (2018-2023) & (US$ Million)
Table 75. Boehringer Ingelheim Recent Development
Table 76. GlaxoSmithKline Company Detail
Table 77. GlaxoSmithKline Business Overview
Table 78. GlaxoSmithKline Autoimmune Disorders Treatment Product
Table 79. GlaxoSmithKline Revenue in Autoimmune Disorders Treatment Business (2018-2023) & (US$ Million)
Table 80. GlaxoSmithKline Recent Development
Table 81. AstraZeneca Company Detail
Table 82. AstraZeneca Business Overview
Table 83. AstraZeneca Autoimmune Disorders Treatment Product
Table 84. AstraZeneca Revenue in Autoimmune Disorders Treatment Business (2018-2023) & (US$ Million)
Table 85. AstraZeneca Recent Development
Table 86. Sanofi Company Detail
Table 87. Sanofi Business Overview
Table 88. Sanofi Autoimmune Disorders Treatment Product
Table 89. Sanofi Revenue in Autoimmune Disorders Treatment Business (2018-2023) & (US$ Million)
Table 90. Sanofi Recent Development
Table 91. Merck Company Detail
Table 92. Merck Business Overview
Table 93. Merck Autoimmune Disorders Treatment Product
Table 94. Merck Revenue in Autoimmune Disorders Treatment Business (2018-2023) & (US$ Million)
Table 95. Merck Recent Development
Table 96. Pfizer Company Detail
Table 97. Pfizer Business Overview
Table 98. Pfizer Autoimmune Disorders Treatment Product
Table 99. Pfizer Revenue in Autoimmune Disorders Treatment Business (2018-2023) & (US$ Million)
Table 100. Pfizer Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Autoimmune Disorders Treatment Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Autoimmune Disorders Treatment Market Share by Type: 2022 VS 2033
Figure 3. Bridge Therapy Features
Figure 4. Recombinant Technology Features
Figure 5. Fecal Bacteriotherapy Features
Figure 6. Hematopoietic Stem-cell Transplantation Features
Figure 7. Phototherapy Features
Figure 8. Helminthic Therapy Features
Figure 9. Activation-induced Assays Features
Figure 10. Global Autoimmune Disorders Treatment Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 11. Global Autoimmune Disorders Treatment Market Share by Application: 2022 VS 2033
Figure 12. Systemic Autoimmune Diseases Case Studies
Figure 13. Localized Autoimmune Diseases Case Studies
Figure 14. Autoimmune Disorders Treatment Report Years Considered
Figure 15. Global Autoimmune Disorders Treatment Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 16. Global Autoimmune Disorders Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 17. Global Autoimmune Disorders Treatment Market Share by Region: 2022 VS 2033
Figure 18. Global Autoimmune Disorders Treatment Market Share by Players in 2022
Figure 19. Global Top Autoimmune Disorders Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autoimmune Disorders Treatment as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Autoimmune Disorders Treatment Revenue in 2022
Figure 21. North America Autoimmune Disorders Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. North America Autoimmune Disorders Treatment Market Share by Country (2018-2033)
Figure 23. United States Autoimmune Disorders Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Canada Autoimmune Disorders Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Autoimmune Disorders Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Europe Autoimmune Disorders Treatment Market Share by Country (2018-2033)
Figure 27. Germany Autoimmune Disorders Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. France Autoimmune Disorders Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. U.K. Autoimmune Disorders Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Italy Autoimmune Disorders Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Russia Autoimmune Disorders Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Nordic Countries Autoimmune Disorders Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific Autoimmune Disorders Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Asia-Pacific Autoimmune Disorders Treatment Market Share by Region (2018-2033)
Figure 35. China Autoimmune Disorders Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Japan Autoimmune Disorders Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. South Korea Autoimmune Disorders Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Southeast Asia Autoimmune Disorders Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. India Autoimmune Disorders Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Australia Autoimmune Disorders Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America Autoimmune Disorders Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Latin America Autoimmune Disorders Treatment Market Share by Country (2018-2033)
Figure 43. Mexico Autoimmune Disorders Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Brazil Autoimmune Disorders Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa Autoimmune Disorders Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East & Africa Autoimmune Disorders Treatment Market Share by Country (2018-2033)
Figure 47. Turkey Autoimmune Disorders Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Saudi Arabia Autoimmune Disorders Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Abbott Laboratories Revenue Growth Rate in Autoimmune Disorders Treatment Business (2018-2023)
Figure 50. Roche Diagnostics Revenue Growth Rate in Autoimmune Disorders Treatment Business (2018-2023)
Figure 51. Siemens Healthcare Revenue Growth Rate in Autoimmune Disorders Treatment Business (2018-2023)
Figure 52. Johnson & Johnson Revenue Growth Rate in Autoimmune Disorders Treatment Business (2018-2023)
Figure 53. Boehringer Ingelheim Revenue Growth Rate in Autoimmune Disorders Treatment Business (2018-2023)
Figure 54. GlaxoSmithKline Revenue Growth Rate in Autoimmune Disorders Treatment Business (2018-2023)
Figure 55. AstraZeneca Revenue Growth Rate in Autoimmune Disorders Treatment Business (2018-2023)
Figure 56. Sanofi Revenue Growth Rate in Autoimmune Disorders Treatment Business (2018-2023)
Figure 57. Merck Revenue Growth Rate in Autoimmune Disorders Treatment Business (2018-2023)
Figure 58. Pfizer Revenue Growth Rate in Autoimmune Disorders Treatment Business (2018-2023)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed